# Thymus Transplantation With Immunosuppression

> **NCT00579709** · PHASE1 · COMPLETED · sponsor: **Sumitomo Pharma Switzerland GmbH** · enrollment: 15 (actual)

## Conditions studied

- DiGeorge Syndrome
- DiGeorge Anomaly
- Complete DiGeorge Anomaly
- Complete DiGeorge Syndrome

## Interventions

- **BIOLOGICAL:** Thymus Tissue for Transplantation

## Key facts

- **NCT ID:** NCT00579709
- **Lead sponsor:** Sumitomo Pharma Switzerland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2006-12
- **Final completion:** 2019-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579709, "Thymus Transplantation With Immunosuppression". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00579709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*